Celularity

Celularity is a biotech company in Florham Park, United States, founded in 2016. It has raised $895.0M across 4 rounds, most recently a $500.0M Extension Round in 2021 (est.).

The Next Evolution in Cellular Medicine

Employees
51–200
Founded
2016
Business Model
B2B
Total Funding
$895.0M
Last Round
$500.0M Extension RoundJan 2021
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds for this company. The full record is or through the API.

About

Celularity, headquartered in Florham Park, New Jersey, is a clinical and commercial stage biotechnology company leading the next evolution in cellular and regenerative medicine. The company's innovative approach harnesses the unique therapeutic potential locked within the postpartum placenta — nature's immunotherapy engine — to develop off-the-shelf allogeneic placenta-derived cellular therapies including mesenchymal-like adherent stromal cells (MLASCs), Natural Killer (NK) cells, and engineered T cells including CAR-T cells. Celularity targets serious unmet medical needs across age-related diseases, cancer, infectious diseases, and degenerative conditions. Celularity has more than 15 active and completed clinical trials and operates an approximately 150,000-square-foot cGMP-ready manufacturing facility in Florham Park, NJ.

Summary

It lists 51–200 employees. It has raised $895.0M in total across 4 rounds, most recently a $500.0M Extension Round in 2021 (est.).

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Extension RoundExtension Round2021 (est.)
$500.0M

Sign up to see all 5 events

Funding: Venture Round through Extension Round. Amounts, valuations, and investors where available.

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Celularity on Indexed.vc
<a href="https://indexed.vc/companies/celularity"><img src="https://indexed.vc/api/badge/company/celularity" alt="Celularity on Indexed.vc" width="260" height="76" /></a>